Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Contralateral Sciatic Block for Phantom and Residual Limb Pain
NCT05046639Phase 4Terminated
- Sponsor
- Northwestern University
- Start
- Sep 2021
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lidocaine in phantom limb pain (PLP), Residual limb pain (RLP), sponsored by Northwestern University. Started Sep 2021; status: terminated.
02
Drugs
lidocaine
03
Conditions
phantom limb pain (PLP)Residual limb pain (RLP)
Beyond the preview
Go deeper on NCT05046639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05046639.